You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (47) |
Back to Search
Sustained Release Fixed Dose Combination Products in Microparticle-Filled Straw developed using the MicroCoatTM technology
- At: PSWC2020 (2020)
- Type: Poster
- By: PATEL, Kavil (University of Hertfordshire, United Kingdom)
- Co-author(s): Kavil Patel: School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom
Darragh Murnane: School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom
Craig Richardson: Fluid Pharma Ltd, Leeds, United Kingdom
Fang Liu: Fluid Pharma Ltd, Leeds, United Kingdom - Abstract:
Background
Metformin and gliclazide combination treatments are used for the increasingly prevalent type II diabetes mellitus. Sustained release (SR) formulations improve patient compliance however they are large tablets and not suited to patients who suffer from dysphagia.Purpose
The project aim is to develop an easy to use metformin and.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026